, Volume 5, Issue 2, pp 101-104
Date: 16 Jun 2012

The role of biomarkers in the choice of therapy in breast cancer

Rent the article at a discount

Rent now

* Final gross prices may vary according to local VAT.

Get Access


The discovery of prognostic and predictive biomarkers, enabling the application of more individualized therapies to different molecular breast cancer (BC) subtypes, has already led to changes in BC treatment during the past decades. In this review, the importance of established as well as of emerging biomarkers, currently undergoing testing for technical validity and clinical utility, is discussed.